awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33392920-5F2CC8A6-8E0B-4F98-A03C-533764C6DA40
Q33392920-5F2CC8A6-8E0B-4F98-A03C-533764C6DA40
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33392920-5F2CC8A6-8E0B-4F98-A03C-533764C6DA40
Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity.
P2860
Q33392920-5F2CC8A6-8E0B-4F98-A03C-533764C6DA40
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33392920-5F2CC8A6-8E0B-4F98-A03C-533764C6DA40
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f5edd3a2b68e2cdaabc106a85447a982f5bbd6b1
P2860
bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation.